References
- Amisano , G and Giorgetti , ML . 2008 . Entry into new pharmaceutical submarkets: the role of submarket concentration . Available at SSRN: http://ssrn.com/abstract=1118122 (accessed 10 October 2011)
- Amisano , G and Giorgetti , ML . 2011 . Entry in pharmaceutical submarkets: a Bayesian panel probit analysis . Journal of Applied Econometrics , forthcoming
- Arellano , M and Carrasco , R . 2003 . Binary choice panel data models with predetermined variables . Journal of Econometrics , 115 : 125 – 57 .
- Biewen , M . 2004 . Measuring state dependence in individual poverty status: are there feedback effects to employment decisions and household compositions? , IZA Discussion Paper No. 1138 .
- Bottazzi , G , Dosi , G , Lippi , M , Pammolli , F and Riccaboni , M . 2001 . Innovation and corporate growth in the evolution of the drug industry . International Journal of Industrial Organization , 19 : 1161 – 87 .
- Caves , RE , Whinston , MD and Hurwitz , MA . 1991 . “ Patent expiration, entry, and competition in the US pharmaceutical industry ” . In Brooking Papers on Economic Activity: Microeconomics, 1991 1 – 66 .
- Chib , S and Jeliazkov , I . 2004 . Semiparametric hierarchical Bayes analysis of discrete panel data with state dependence Working Paper, Department of Economics, University of California-Irvine
- Danzon , PM , Wang , YR and Wang , L . 2005 . The impact of price regulation on the launch delay of new drugs – evidence from twenty-five major markets in the 1990s . Health Economics , 14 : 269 – 92 .
- Di Masi , J . 2001 . Winners and losers in new drug innovation . Medical Marketing and Media , 36 : 99 – 110 .
- Geroski , PA . 1999 . The growth of firms in theory and practice , CEPR Discussion Paper No. 2092 .
- Giorgetti , ML . 2006 . “ Scope economies in the pharmaceutical sector ” . In International Review of Economics , Vol. 53 , 373 – 401 . Berlin/Heidelberg : Springer .
- Henderson , R and Cockburn , I . 1996 . Scale, scope, and spillovers: the determinants of research productivity in drug discovery . RAND Journal of Economics , 27 : 32 – 59 .
- Honoré , BE and Kyriazidou , E . 2000 . Panel data discrete choice models with lagged dependent variables . Econometrica , 68 : 839 – 74 .
- Honorė , BE and Lewbel , A . 2002 . Semiparametric binary choice panel data models without strictly exogenous regressors . Econometrica , 70 : 2053 – 63 .
- Klepper , S and Thompson , P . 2006 . Submarkets and the evolution of market structure . RAND Journal of Economics , 37 : 861 – 86 .
- Kyle , M . 2006 . The role of firms characteristics in pharmaceutical product launches . RAND Journal of Economics , 37 : 602 – 18 .
- Lanjouw , J . 2005 . Patents, price controls, and access to new drugs: how policy affects global market entry , NBER Working Paper .
- Matraves , C . 1999 . Market structure, R&D and advertising in the pharmaceutical industry . Journal of Industrial Economics , 47 : 169 – 94 .
- Mitchell , M . 2000 . The scope and organization of production: firm dynamics over the learning curve . RAND Journal of Economics , 31 : 180 – 205 .
- Penrose , E . 1959 . The Theory of Growth of the Firm , Basil Blackwell, Oxford .
- Scott , JT . 1993 . Purposive Diversification and Economic Performance , Cambridge : Cambridge University Press .
- Scott Morton , F . 1997 . Entry decision in the generic pharmaceutical industry , NBER Working Paper .
- Sutton , J . 1998 . Technology and Market Structure , Cambridge , MA : MIT Press .
- Train , KE . 2003 . Discrete Choice Methods with Simulation , Cambridge : Cambridge University Press .
- Wooldridge , JM . 2005 . Simple solutions to the initial conditions problem in dynamic, nonlinear panel data models with unobserved heterogeneity . Journal of Applied Econometrics , 20 : 39 – 54 .